Demetri George 4
4 · Blueprint Medicines Corp · Filed Sep 24, 2020
Insider Transaction Report
Form 4
Demetri George
Director
Transactions
- Sale
Common Stock
2020-09-22$85.00/sh−1,704$144,840→ 4,320 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted on December 18, 2017 and modified on November 7, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.